Neok001
Locally Advanced (Unresectable) or Metastatic Solid Tumors
NEOK Bio, Inc.antibody_drug_conjugatePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Locally Advanced (Unresectable) or Metastatic Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ssgj-612 Shenyang Sunshine Pharmaceutical Co., LTD. | Phase 2 | CCC |
Ssgj-705 Shenyang Sunshine Pharmaceutical Co., LTD. | Phase 2 | CCC |
txn10128 Txinno Bioscience Inc. | Phase 1 | CC |
Irinotecan Txinno Bioscience Inc. | Phase 1 | CC |
Neok002 NEOK Bio, Inc. | Phase 1 | CC |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →